Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: a phase IV, randomized, open-label, controlled study.
about
Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults.Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.ICU-treated influenza A(H1N1) pdm09 infections more severe post pandemic than during 2009 pandemic: a retrospective analysis.Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.
P2860
Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: a phase IV, randomized, open-label, controlled study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Immunogenicity and safety of a ...... open-label, controlled study.
@ast
Immunogenicity and safety of a ...... open-label, controlled study.
@en
type
label
Immunogenicity and safety of a ...... open-label, controlled study.
@ast
Immunogenicity and safety of a ...... open-label, controlled study.
@en
prefLabel
Immunogenicity and safety of a ...... open-label, controlled study.
@ast
Immunogenicity and safety of a ...... open-label, controlled study.
@en
P2093
P1433
P1476
Immunogenicity and safety of a ...... open-label, controlled study.
@en
P2093
Anne Schuind
David W Vaughn
Jin-Soo Lee
Mamadou Dramé
Patricia Izurieta
Seong-Heon Wie
P304
P356
10.1016/J.VACCINE.2015.04.027
P407
P50
P577
2015-04-21T00:00:00Z